Climb Bio Financial Overview
Climb Bio's market cap is currently $330.69M. The company's EPS TTM is $-0.19; its P/E ratio is -6.46; Climb Bio is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
